Últimas subidas - Age-Related Macular Degeneration - Dry
|
Reticular pseudodrusenvista 102 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 108 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 105 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 93 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 95 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 88 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 107 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 105 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 98 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 106 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 91 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 98 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 95 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 99 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 100 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 109 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 105 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 92 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 92 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 87 vecesFebrero 23, 2025
|
|
Reticular pseudodrusenvista 89 vecesFebrero 23, 2025
|
|
54 year old female with a lot of drusenvista 88 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 85 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 87 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 82 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 102 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 99 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 91 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
54 year old female with a lot of drusenvista 92 vecesVA 20/12 OD, 20/16 OS - no symptomsDiciembre 21, 2024
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 140 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 142 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 131 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 125 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 144 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 144 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 136 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 125 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvista 137 veces69 year old healthy woman with 20/20 vision and no visual complaintsSeptiembre 22, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 121 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 113 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 104 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 102 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 109 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 130 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 128 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 111 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvista 130 veces80 year old female with 20/50 vision in both eyes. Mild blurringSeptiembre 17, 2023
|
|
Optic Disc Melanocytoma - Atypicalvista 249 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 221 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 220 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 221 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 218 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 225 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 225 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 224 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 237 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 229 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Optic Disc Melanocytoma - Atypicalvista 255 veces45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 234 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 222 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 224 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 230 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 219 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 220 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 208 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 233 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 205 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vista 196 veces65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.Agosto 17, 2022
|
|
Soft Drusenvista 245 veces63 year old female with 20/16 vision both eyesOctubre 17, 2021
|
|
Soft Drusenvista 263 veces63 year old female with 20/16 vision both eyesOctubre 17, 2021
|
|
Soft Drusenvista 245 veces63 year old female with 20/16 vision both eyesOctubre 17, 2021
|
|
Soft Drusenvista 240 veces63 year old female with 20/16 vision both eyesOctubre 17, 2021
|
|
Soft Drusenvista 242 veces63 year old female with 20/16 vision both eyesOctubre 17, 2021
|
|
Soft Drusenvista 278 veces63 year old female with 20/16 vision both eyesOctubre 17, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 257 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 233 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 243 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 249 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 255 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 249 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 275 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 258 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 250 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 287 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 269 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 235 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 259 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 245 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 223 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 252 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 244 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 267 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 266 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 270 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 220 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 239 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 265 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 260 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 259 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvista 284 veces79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)Octubre 16, 2021
|
|
| 582 archivos en 6 página(s) |
1 |
 |
|
|
|
